Clinical trials are clinical research involving human beings. At CAIMED we have constituted ourselves as a Clinical Investigation Center that develops clinical trials in an effective way, according to each protocol, including at least the assigned subjects, in the established times and with zero errors; in diverse therapeutic areas and in a responsible way with the research subjects.
We are experts in carrying out clinical studies with vaccines. We have made significant contributions to the development of vaccines against AH1N1, influenza, HPV, Clostridium Difficile, meningococcus, varicella zoster and dengue. Over the course of our Clinical Research Centers’ history, we have included more than 15,000 participants in the clinical trials with vaccines that have been conducted.
We have developed clinical studies with drugs in multiple therapeutic areas such as: diabetes, dyslipidemia, osteoporosis, high blood pressure, atherosclerosis, heart failure, coronary disease, hemophilia and Chagas disease. We have the experience, infrastructure and knowledge of our professionals for the development of clinical studies with drugs.
We have a team of qualified professionals and the latest technology to carry out cosmetic studies that we perform, that meet the highest quality standards, patient safety and the outcome of the studies.
In CAIMED Center of Clinical Investigation we also carry out clinical studies that demonstrate the security and effectiveness for the use in humans of:
We have our own medical informatics software, MetricsMed®. In which we manage all the information of the Research Center, allowing remote monitoring and all the management of the Ethics Committee. Platform verified with all CRF21-11 requirements.
We have a biobank service for the filing, care and replacement of human biological samples for clinical research, we encode and classify the samples according to their origin, we manage, we take care of all legal aspects and we process the samples according to the established research protocols.
We manage all regulatory aspects of your clinical study, related to your research protocol, from the process of translation and submission of documents to the research ethics committees, to the notification of pharmacological follow-up, through the submission of the protocols of Investigation in the face of the regulatory entity.
We are experts in recruiting for clinical research, we generate strategies that allow us to reach the expected number of subjects; We have subject databases for clinical studies with the necessary conditions; we carry out population surveys and carry out continuous monitoring to complete the clinical study successfully.
We have a specialized health Call Center for the development of clinical studies and follow-up of subjects.